enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Padeliporfin - Wikipedia

   en.wikipedia.org/wiki/Padeliporfin

   Padeliporfin, sold under the brand name Tookad, is a medication used to treat men with prostate cancer. [1] [2] It is used in the form padeliporfin di-potassium.[2]The most common side effects include problems with urinating (pain, inability to pass urine, strong urge to pass urine, frequent urination, and incontinence), sexual problems (erectile dysfunction and ejaculation failure), blood in ...

3. Proxalutamide - Wikipedia

   en.wikipedia.org/wiki/Proxalutamide

   Proxalutamide (developmental code name GT-0918) is a nonsteroidal antiandrogen (NSAA) – specifically, a selective high-affinity silent antagonist of the androgen receptor (AR) – which is under development by Suzhou Kintor Pharmaceuticals, inc., a subsidiary of Kintor Pharmaceutical Limited, for the potential treatment of COVID-19, prostate cancer, and breast cancer.

4. Sipuleucel-T - Wikipedia

   en.wikipedia.org/wiki/Sipuleucel-T

   Sipuleucel-T, sold under the brand name Provenge, developed by Dendreon Pharmaceuticals, LLC, is a cell-based cancer immunotherapy for prostate cancer (CaP). [ 1 ] [ 3 ] [ 4 ] It is an autologous cellular immunotherapy.

5. What to Know About Complementary Therapies for Prostate Cancer

   www.aol.com/know-complementary-therapies...

   “Two servings of fish per week after diagnosis was associated with a 17% lower risk of prostate cancer recurrence,” wrote the Prostate 8 team, citing a study in the journal Cancer Causes and ...

6. Leuprorelin - Wikipedia

   en.wikipedia.org/wiki/Leuprorelin

   On 24 March 2022, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion, recommending the granting of a marketing authorization for the medicinal product Camcevi, intended for the treatment of the cancer of the prostate in adult men when the cancer is "hormone-dependent ...

7. Relugolix - Wikipedia

   en.wikipedia.org/wiki/Relugolix

   Relugolix, sold under the brand names Orgovyx and Relumina among others, is a gonadotropin-releasing hormone antagonist (GnRH receptor antagonist) medication which is used in the treatment of prostate cancer in men and uterine fibroids in women.